BFM 89.9

Podcast  >  The Bigger Picture  >  Health and Living  >  Can We Afford The First Pill for COVID-19?

Can We Afford The First Pill for COVID-19?

Sangeeta Shashikant, Programme Director on Development & Intellectual Property, Third World Network

02-Nov-21 16:35

Can We Afford The First Pill for COVID-19?

Merck & Co’s oral antiviral for COVID-19 is being called a “game-changer”, as it would be the first pill available to treat early infection. In another first, the company has agreed to a licensing deal that will allow the drug to be made and sold cheaply in 105 low-income countries. We ask Sangeeta Shashikant, Programme Director on Development & Intellectual Property, Third World Network, whether this move will be enough to make the drug accessible, especially when rich countries look set to hoard supplies amid already existing vaccine inequity.

Listen to Part 1 here, where we explore how molnupiravir works and how it could change the way COVID-19 is managed.

Image credit: The Intercept

Produced by: Lim Sue Ann and Tee Shiao Eek


Download the BFM mobile app. Stay at home and stay up-to-date.

Tags:  The Bigger PictureHealth & LivingCOVID-19Merckmolnupiravirantiviralremdesivirequitygenericintellectual propertymedicines patent poolIP waiverConsumer Goods/ServicesGovernment/Regulatory/Policy MakingHealthcare, Pharma, BiotechOther personality interviewsPolitics, News, Current AffairsHealthPersonal FinanceInvestmentsFinancial LiteracyYoung FinancePersonal DevelopmentEntrpreneurshipPoliticsSocial IssuesBusiness AnalysisAutolaw & legal mattersHealth PolicyDiseases & ConditionsMental HealthHealthy LivingFitnessMedical Innovation and TechnologySMEMarketsScience


Life
Dan Lain-Lain

Share this podcast




Play / Pause

Listen now :

Today’s Shows